HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nevus anemicus. Donor-dominant defect.

Abstract
Histologic, pharmacologic, and exchange transplant studies were performed on a patient with nevus anemicus. Histologic examination disclosed no abnormalities. The only pharmacologic stimulus that produced erythema within the nevus was the alpha-blocking agent, phentolamine mesylate. Results of the transplant studies demonstrated donor dominance. This suggests that the defect in the nevus anemicus is attributable to increased sensitivity of the blood vessels to catecholamines rather than to increased alpha-adrenergic stimulation.
AuthorsR H Daniel, W R Hubler, J E Wolf, W R Holder
JournalArchives of dermatology (Arch Dermatol) Vol. 113 Issue 1 Pg. 53-6 (Jan 1977) ISSN: 0003-987X [Print] United States
PMID318817 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Propranolol
  • Phentolamine
Topics
  • Hemangioma (blood supply, etiology)
  • Humans
  • Male
  • Middle Aged
  • Phentolamine (pharmacology)
  • Propranolol (pharmacology)
  • Skin Neoplasms (blood supply, etiology)
  • Skin Transplantation
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: